Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michio Sata

Showing results (41-50 of 416) with videos related to

Pageof 42
Sort By:
Clinical and Translational Gastroenterology|July 9, 2016
Successful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting AntiviralsYumiko Nagao, Kanae Kimura, Yuji Kawahigashi, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 2, 2010
Aminofeel improves the sensitivity to taste in patients with HCV-infected liver diseaseYumiko Nagao, Hisako Matsuoka, Takumi Kawaguchi, et al.
World Journal of Gastroenterology|April 25, 2013
Dipeptidyl peptidase-4: a key player in chronic liver diseaseMinoru Itou, Takumi Kawaguchi, Eitaro Taniguchi, et al.
Medical Molecular Morphology|April 1, 2006
Angiogenic cell therapy for hepatic fibrosisTakato Ueno, Toru Nakamura, Takuji Torimura, et al.
The American Journal of Gastroenterology|August 23, 2002
Fenofibrate treatment in patients with primary biliary cirrhosisHiromasa Ohira, Yukio Sato, Takato Ueno, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|June 13, 2008
[HCV or HBV infection self-disclosure to dentists]Yumiko Nagao, Takumi Kawaguchi, Tatsuya Ide, et al.
Virology Journal|November 24, 2012
Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective studyYumiko Nagao, Takumi Kawaguchi, Tatsuya Ide, et al.
International Journal of Molecular Medicine|July 5, 2014
Exendin‑4, a glucagon‑like peptide‑1 receptor agonist, modulates hepatic fatty acid composition and Δ‑5‑desaturase index in a murine model of non‑alcoholic steatohepatitisTakumi Kawaguchi, Minoru Itou, Eitaro Taniguchi, et al.
Hepatology (Baltimore, Md.)|May 13, 2011
Branched-chain amino acids as pharmacological nutrients in chronic liver diseaseTakumi Kawaguchi, Namiki Izumi, Michael R Charlton, et al.
Microbiology and Immunology|July 24, 2004
Antibody reactive to a hepatitis C virus (HCV)-derived peptide capable of inducing HLA-A2 restricted cytotoxic T lymphocytes is detectable in a majority of HCV-infected individuals without HLA-A2 restrictionYukari Takao, Akira Yamada, Shigeru Yutani, et al.
Pageof 42

Showing results (41-50 of 416) with videos related to

Sort By:
Pageof 42
Clinical and Translational Gastroenterology|July 9, 2016
Successful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting AntiviralsYumiko Nagao, Kanae Kimura, Yuji Kawahigashi, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 2, 2010
Aminofeel improves the sensitivity to taste in patients with HCV-infected liver diseaseYumiko Nagao, Hisako Matsuoka, Takumi Kawaguchi, et al.
World Journal of Gastroenterology|April 25, 2013
Dipeptidyl peptidase-4: a key player in chronic liver diseaseMinoru Itou, Takumi Kawaguchi, Eitaro Taniguchi, et al.
Medical Molecular Morphology|April 1, 2006
Angiogenic cell therapy for hepatic fibrosisTakato Ueno, Toru Nakamura, Takuji Torimura, et al.
The American Journal of Gastroenterology|August 23, 2002
Fenofibrate treatment in patients with primary biliary cirrhosisHiromasa Ohira, Yukio Sato, Takato Ueno, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|June 13, 2008
[HCV or HBV infection self-disclosure to dentists]Yumiko Nagao, Takumi Kawaguchi, Tatsuya Ide, et al.
Virology Journal|November 24, 2012
Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective studyYumiko Nagao, Takumi Kawaguchi, Tatsuya Ide, et al.
International Journal of Molecular Medicine|July 5, 2014
Exendin‑4, a glucagon‑like peptide‑1 receptor agonist, modulates hepatic fatty acid composition and Δ‑5‑desaturase index in a murine model of non‑alcoholic steatohepatitisTakumi Kawaguchi, Minoru Itou, Eitaro Taniguchi, et al.
Hepatology (Baltimore, Md.)|May 13, 2011
Branched-chain amino acids as pharmacological nutrients in chronic liver diseaseTakumi Kawaguchi, Namiki Izumi, Michael R Charlton, et al.
Microbiology and Immunology|July 24, 2004
Antibody reactive to a hepatitis C virus (HCV)-derived peptide capable of inducing HLA-A2 restricted cytotoxic T lymphocytes is detectable in a majority of HCV-infected individuals without HLA-A2 restrictionYukari Takao, Akira Yamada, Shigeru Yutani, et al.
Pageof 42